Search keyWord :

NUS researchers boost chemotherapy uptake in breast cancer treatment with localised magnetic fields

Jan 8, 2025

A recent study explained the mechanisms by which pulsed electromagnetic field therapy enhances doxorubicin uptake,paving the way for precision-driven cancer therapies with fewer side effects

ASTON MARTIN ARAMCO FORMULA ONE® TEAM ANNOUNCE PEPPERSTONE AS OFFICAL TRADING PARTNER

Jan 8, 2025

Aston Martin Aramco announce long-term partnership with Pepperstone A global leader in online trading,Pepperstone joins as Global Forex and Trading Partner

CLO Virtual Fashion Opens New Office in Vietnam in Response to Growth in Southeast Asia

Jan 8, 2025

CLO Virtual Fashion opens a second Southeast Asia office in Ho Chi Minh City. The decision to establish a presence in Vietnam underscoresCLO Virtual Fashion\'s commitment to supporting local clients a

Yaber at CES 2025: Color the Movie Night

Jan 8, 2025

Enjoy Stunning Visuals with Yaber\'s Powerful K300s,L2 Plus,and T2 Series LAS VEGAS,Jan. 7,2025-- Yaber,a pioneer in entertainment projectors,introduces three groundbreaking models: the ultra-short t

SHOPLINE, the Commerce SaaS and Solution Provider, Teams Up with Tessera to Revolutionize Customer Experience and Elevate Brand Impact Across Asia

Jan 8, 2025

TAIPEI,Jan. 7,2025-- As the future of retail shifts towards an integrated omnichannel ecosystem,it is projected to become a trillion-dollar industry. While many businesses already possess strong produ

Colorful Inc. Launches Japan Market Entry Services to Empower APAC Businesses

Jan 8, 2025

Empowering businesses with strategic support for a smooth and successful entry into Japan\'s dynamic market

Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma

Jan 8, 2025

Back to media releases Next media release LONDON,Jan. 7,2025-- Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflorni

WuXi Biologics Announces Agreement with Candid Therapeutics on Trispecific T-cell Engager

Jan 8, 2025

SHANGHAI and SAN DIEGO,Jan. 7,2025-- WuXi Biologics ("WuXi Bio") (2269. HK),a leading global Contract Research,Development,and Manufacturing Organization (CRDMO),today announced an agreement

The Registrational Clinical Data of Glecirasib was Published in Nature Medicine

Jan 8, 2025

BEIJING,SHANGHAI and BOSTON,Jan. 7,2025-- Jacobio Pharma (1167.HK),a clinical-stage oncology company focusing on undruggable targets announced today that the data from a registrational clinical trial

Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

Jan 8, 2025

NEW YORK,Jan. 7,2025-- Aquaron Acquisition Corp. (NASDAQ: AQU,the "Company"),a special purpose acquisition company,announced today that HUTURE Ltd. ("Huture") has deposited into th

1 ... 499 500 501 502 503 504 505 ... 1285